Synbindin Downregulation Participates in Slit Diaphragm Dysfunction

Area of Science:

• Nephrology
• Molecular Biology
• Cell Biology

Background:

• Synbindin, initially identified in neurons, is also present in renal glomeruli.
• Puromycin aminonucleoside (PAN) nephropathy, a model for minimal-change nephrotic syndrome, shows reduced synbindin mRNA expression in glomeruli.

Purpose of the Study:

• To investigate synbindin expression and function in podocytes during nephrotic conditions.
• To determine if synbindin can serve as an early biomarker for podocyte injury.

Main Methods:

• Immunohistochemistry and RT-PCR were used to analyze synbindin expression in rat models of nephrotic syndrome.
• Gene silencing using siRNA in cultured human podocytes was performed to elucidate synbindin's function.

Main Results:

• Synbindin is localized to the slit diaphragm area of podocytes.
• Decreased synbindin mRNA and altered protein staining were observed early in nephrotic models, preceding proteinuria.
• Synbindin knockdown in podocytes led to cellular shape changes, altered actin structure, reduced ephrin-B1, and increased SV2B expression.

Conclusions:

• Synbindin plays a role in maintaining podocyte foot processes and slit diaphragm integrity.
• Downregulation of synbindin contributes to slit diaphragm dysfunction in nephrotic syndrome.
• Synbindin serves as a potential early marker for detecting podocyte injury.